Active Studies: Pediatric Diabetes

Doctors Hospital at Renaissance is currently conducting the following trials in the area of Pediatric Diabetes:

Status Clinical Trial # Title of Study Location Contact Number Learn More Principal Investigator
Closed for Enrollment NCT01485614 Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083) Doctors Hospital at Renaissance 956-362-2378 Click Here for more information Marcel Twahirwa, MD
Closed for Enrollment NCT01760447 A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289) Doctors Hospital at Renaissance 956-362-2379 Click Here for more information Marcel Twahirwa, MD
Closed for Enrollment NCT01541215 Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes (Ellipse™) Doctors Hospital at Renaissance 956-362-2378 Click Here for more information Marcel Twahirwa, MD
Closed for Enrollment NCT02131272 A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin Doctors Hospital at Renaissance 956-362-2378 Click Here for more information Marcel Twahirwa, MD
Not Actively Recruiting NCT02065791 Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) Doctors Hospital at Renaissance 956-362-2378 Click Here for more Information  
Not Actively Recruiting NCT02488785 Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With Type 2 Diabetes Mellitus Doctors Hospital at Renaissance 956-362-2379 Click Here for more Information  
Not Actively Recruiting NCT02460978 A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects with Type 1 Diabetes Mellitus -Study Two Doctors Hospital at Renaissance 956-362-2379 Click Here for more Information  

Doctors Hospital at Renaissance

 © Copyright. All rights reserved.

5501 S. McColl Rd. Edinburg Texas 78539 | (956) 362-8677 | 956-DOCTORS

As required by the 2012 Hospital Outpatient Prospective Payment; Ambulatory Surgical Center Payment;
Hospital Value-Based Purchasing Program; Physician Self-Referral; and Patient Notification Requirements
in Provider Agreements
final rule, Doctors Hospital at Renaissance, Ltd is disclosing that it is seeking an expansion
exception under Section 6001 of the Affordable Care Act of 2010.

Doctors Hospital at Renaissance proudly meets the federal definition of a "physician-owned hospital" (42 CFR § 489.3). As required by law, a list of the hospital's physician owners and investors is available at here. DHR, Ltd. and its affiliated entities comply with applicable Federal civil rights laws and do not discriminate on the basis of race, color, national origin, age, disability, or sex.